HighLife Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $36.5M

  • Investors
  • 8

HighLife General Information

Description

Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The company's system targets optimal treatment outcomes as it can be delivered through a transseptal passage via the femoral vein in a reversible manner and self-locates inside the native annulus, enabling physicians to reduce trauma to the patients while carrying out severe heart surgery procedures.

Contact Information

Website
www.highlifemedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 avenue de Suffren
  • 75015 Paris
  • France
+33 01 00 00 00 00
Primary Industry
Therapeutic Devices
Vertical(s)
HealthTech
Corporate Office
  • 100 avenue de Suffren
  • 75015 Paris
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HighLife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 10-Jan-2019 $36.5M 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 29-Jul-2017 000.00 0000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 26-Nov-2012 $6.87M $6.87M 000.00 Completed Generating Revenue
To view HighLife’s complete valuation and funding history, request access »

HighLife Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B Shares 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
A2 Shares 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Shares 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
A Shares 1,634,241 $0.011407 $2.93 $2.93 1x $2.93 3.02%
Ordinary 450,770 $0.011407 $2.93 $2.93 1x $2.93 0.83%
To view HighLife’s complete cap table history, request access »

HighLife Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The com
Therapeutic Devices
Paris, France
70 As of 2023
000.00
000.00 0000-00-00
00000000000 000.00

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
00000000000 0000000
Tel Aviv, Israel
00 As of 0000
000.00
0000000000 0 000.00

000000

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
00000000000 0000000
Milan, Italy
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HighLife Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Coramaze Technologies Venture Capital-Backed Tel Aviv, Israel 00 000.00 0000000000 0 000.00
InnovHeart Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
JenaValve Technology Pending Transaction (M&A) Irvine, CA 000 00000 000000&0 00000
Valcare Venture Capital-Backed Herzliya, Israel 00 000.00 00000000000 000.00
CoreMedic Venture Capital-Backed Radolfzell, Germany 0 00000000000
You’re viewing 5 of 17 competitors. Get the full list »

HighLife Patents

  • 193

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 169

    Granted

  • 17

    Pending

  • 000

    Expiring in next 12 mo

HighLife Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021203899-A1 Transcatheter valve prosthesis and method for implanting the same Pending 26-Jun-2020 0000000000
US-20210401572-A1 Transcatheter valve prosthesis and method for implanting the same Active 26-Jun-2020 0000000000 00
US-11938022-B2 Transcatheter valve prosthesis and method for implanting the same Active 26-Jun-2020 0000000000 000
US-20240189099-A1 Transcatheter valve prosthesis and method for implanting the same Pending 26-Jun-2020 0000000000
US-11484407-B2 Transcatheter valve prosthesis Active 07-Jan-2020 A61F2/2418 0
To view HighLife’s complete patent history, request access »

HighLife Executive Team (8)

Name Title Board Seat
Stefan Pilz Chief Executive Officer
Steve Backer Chief Operating Officer
Malek Nasr Co-Founder & Vice President
Nicolo Piazza Co-Founder
Rüdiger Lange Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

HighLife Board Members (10)

Name Representing Role Since
Anne Osdoit Sofinnova Partners Board Observer 000 0000
Antoine Papiernik Sofinnova Partners Board Member 000 0000
Arnd Kaltofen Ehmann MD VI Partners Board Observer 000 0000
Casey Tansey U.S. Venture Partners Board Member 000 0000
Jose Gordo Self Chairman of the Board 000 0000
You’re viewing 5 of 10 board members. Get the full list »

HighLife Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HighLife Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority 000 0000 000000 0
Jose Gordo Angel (individual) Minority 000 0000 000000 0
Sectoral Asset Management Asset Manager Minority 000 0000 000000 0
U.S. Venture Partners Venture Capital Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

HighLife FAQs

  • When was HighLife founded?

    HighLife was founded in 2010.

  • Who is the founder of HighLife?

    Malek Nasr, Nicolo Piazza, Rüdiger Lange, and Georg Börtlein are the founders of HighLife.

  • Who is the CEO of HighLife?

    Stefan Pilz is the CEO of HighLife.

  • Where is HighLife headquartered?

    HighLife is headquartered in Paris, France.

  • What is the size of HighLife?

    HighLife has 70 total employees.

  • What industry is HighLife in?

    HighLife’s primary industry is Therapeutic Devices.

  • Is HighLife a private or public company?

    HighLife is a Private company.

  • What is the current valuation of HighLife?

    The current valuation of HighLife is 000.00.

  • What is HighLife’s current revenue?

    The current revenue for HighLife is 00000.

  • How much funding has HighLife raised over time?

    HighLife has raised $57.5M.

  • Who are HighLife’s investors?

    Andera Partners, Jose Gordo, Sectoral Asset Management, U.S. Venture Partners, and VI Partners are 5 of 8 investors who have invested in HighLife.

  • Who are HighLife’s competitors?

    Coramaze Technologies, InnovHeart, JenaValve Technology, Valcare, and CoreMedic are some of the 17 competitors of HighLife.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »